Brad Steenwyk

Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro

Case report · The Journal of Heart and Lung Transplantation · 2006 · 47 citations

Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered?

Blood Coagulation & Fibrinolysis · 2007 · Last of 3 authors · 31 citations